Concepedia

Unmesh Shah

US

Statistics

Publications

10

Citations

302

H-Index

10

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

WuXi AppTec (China)

Unmesh Shah is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2006–2016

10

Publications

10

Total Synthesis of (−)-Himgaline

Unmesh Shah, Samuel Chackalamannil, Ashit K. Ganguly et al. · Journal of the American Chemical Society · 2006 · 42 citations

Recent progress in the discovery of adenosine A(2A) receptor antagonists for the treatment of Parkinson's disease.

Unmesh Shah, Robert A. Hodgson · PubMed · 2010 · 37 citations

, , +15

GPR119 agonists: a promising new approach for the treatment of type 2 diabetes and related metabolic disorders.

Unmesh Shah · PubMed · 2009 · 36 citations

, , +22

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor

Santhosh Neelamkavil, Sony Agrawal, Thomas Bara et al. · ACS Medicinal Chemistry Letters · 2015 · 33 citations · Full text

, , +17

Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists

Jason M. Cox, Hong D. Chu, Mariappan V. Chelliah et al. · ACS Medicinal Chemistry Letters · 2016 · 32 citations · Full text

1–5 of 10